Prudential Financial
RAPT

Prudential Financial’s RAPT Therapeutics RAPT Stock Holding History

Prudential Financial’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-6,706
Closed -$108K – 2600
2024
Q3 		$108K Hold
6,706
– – ﹤0.01% 2568
2024
Q2 		$164K Buy
+6,706
New +$310K ﹤0.01% 2505

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Prudential Financial's RAPT Position: Q4 2024 in Review

Prudential Financial sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 6,706 shares — an estimated $108K sold.

Prudential Financial first reported a position in RAPT in Q2 2024 and held it in 2 quarters. The position peaked at $164K in Q2 2024. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • Prudential Financial reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Prudential Financial sold 6,706 RAPT Therapeutics shares in Q4 2024, an estimated $108K.
  • Prudential Financial first reported a position in RAPT Therapeutics in Q2 2024 and held it in 2 quarters.
  • Prudential Financial's RAPT Therapeutics position peaked at $164K in Q2 2024.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on Prudential Financial's 13F filing for Q4 2024, filed 11 Feb 2025.